Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001570 |
---|---|
Receipt number | R000001893 |
Scientific Title | A phase II study of the Cladribine and Rituximab combination therapy for relapsed and refractory indolent B-cell Non-Hodgkin's Lymphoma. |
Date of disclosure of the study information | 2008/12/18 |
Last modified on | 2008/12/12 16:55:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/12/12 16:57:14 |